79 related articles for article (PubMed ID: 1688253)
41. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
[TBL] [Abstract][Full Text] [Related]
42. Clinical evaluation of serum tissue polypeptide specific antigen in patients with thyroid carcinoma.
Suzuki S; Furukawa H; Tsuchiya A
Thyroid; 1999 Sep; 9(9):921-5. PubMed ID: 10524571
[TBL] [Abstract][Full Text] [Related]
43. [Carcinoembryonic antigen (CEA)].
Kinugasa T; Kuroki M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():632-4. PubMed ID: 16149597
[No Abstract] [Full Text] [Related]
44. [CEA in nipple discharge].
Yagihashi A
Nihon Rinsho; 2005 Aug; 63 Suppl 8():635-6. PubMed ID: 16149598
[No Abstract] [Full Text] [Related]
45. Carcinoembryonic antigen and L-fucose in malignant and benign mammary disease.
Wilkinson EJ; Hause LL; Sasse EA; Pattillo RA; Milbrath JR; Lewis JD
Am J Clin Pathol; 1980 May; 73(5):669-75. PubMed ID: 7377133
[TBL] [Abstract][Full Text] [Related]
46. The hepatobiliary disease marker serum alanine aminopeptidase predominantly comprises an isoform of the haematological myeloid differentiation antigen and leukaemia marker CD-13/gp150.
Favaloro EJ; Browning T; Nandurkar H
Clin Chim Acta; 1993 Oct; 220(1):81-90. PubMed ID: 7904544
[TBL] [Abstract][Full Text] [Related]
47. Anti-malignin antibody in serum and other tumor marker determinations in breast cancer.
Thornthwaite JT
Cancer Lett; 2000 Jan; 148(1):39-48. PubMed ID: 10680591
[TBL] [Abstract][Full Text] [Related]
48. [An automated procedure for the determination of the malignancy of tumorous tissue changes].
Wagner R; Pfeiffer J; Thoenes W
Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1195-9. PubMed ID: 6872873
[TBL] [Abstract][Full Text] [Related]
49. Clinical significance of a new isoform of serum alanine aminopeptidase; relationship with liver disease and alcohol consumption.
Sanderink GJ; Artur Y; Paille F; Siest G
Clin Chim Acta; 1989 Jan; 179(1):23-31. PubMed ID: 2563958
[TBL] [Abstract][Full Text] [Related]
50. [Markers of malignant growth as a component of morphologic pattern in human biological fluids].
Shatokhina SN; Shabalin VN
Vopr Onkol; 2010; 56(3):293-300. PubMed ID: 20804050
[No Abstract] [Full Text] [Related]
51. Alanine aminopeptidase in serum: automated optimized assay, and effects of age, sex, smoking, and alcohol consumption in a selected population.
Mueller PW; Phillips DL; Steinberg KK
Clin Chem; 1987 Mar; 33(3):363-6. PubMed ID: 2880680
[TBL] [Abstract][Full Text] [Related]
52. The "Scrimp" technique--a method for the rapid diagnosis of surgical pathology specimens.
Abrahams C
Histopathology; 1978 Jul; 2(4):255-66. PubMed ID: 700602
[TBL] [Abstract][Full Text] [Related]
53. Clinical use of laboratory thyroid tests and investigations.
Lindstedt G; Berg G; Jansson S; Törring O; Valdemarsson S; Warin B; Nyström E
J Int Fed Clin Chem; 1994 Sep; 6(4):136-41. PubMed ID: 10155145
[TBL] [Abstract][Full Text] [Related]
54. Clinical application of the 10-MHz electronic linear array scanner.
Hayashi N; Tamakí N; Hamanaka D; Yamamoto K; Senda M; Yonekura Y; Torizuka K; Kawabuchi M
J Clin Ultrasound; 1985 Jan; 13(1):31-4. PubMed ID: 3920251
[TBL] [Abstract][Full Text] [Related]
55. The correlation between serum levels of cytokeratin tumor markers does reflect their molecular characterization.
Gion M; Mione R; Barioli P; Sartorello P; Dal Zennaro E; Gasparini C; Marconato R
Int J Biol Markers; 1994; 9(2):121-2. PubMed ID: 7523542
[No Abstract] [Full Text] [Related]
56. Reference intervals for plasma alanine aminopeptidase in the Hitachi 737 analyzer, derived from patients with normal biochemical liver profiles.
Hurst PL; Langford NJ; Shue J
Clin Chem; 1988 Dec; 34(12):2583-4. PubMed ID: 2904309
[No Abstract] [Full Text] [Related]
57. CD13 is a useful tool in the differential diagnosis of meningiomas with potential biological and prognostic implications.
Marletta S; Luchini C; Sperandio N; Torresani E; Sorio A; Girolami I; Scarpa A; Eccher A; Ghimenton C
Virchows Arch; 2022 Jun; 480(6):1223-1230. PubMed ID: 35212813
[TBL] [Abstract][Full Text] [Related]
58. Aspartic Aminopeptidase Is a Novel Biomarker of Aggressive Chronic Lymphocytic Leukemia.
Kakodkar P; More S; András K; Papakonstantinou N; Kelly S; Makrooni MA; Ortutay C; Szegezdi E
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664705
[TBL] [Abstract][Full Text] [Related]
59. Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer.
Pang L; Zhang N; Xia Y; Wang D; Wang G; Meng X
Oncotarget; 2016 Nov; 7(47):77854-77864. PubMed ID: 27788483
[TBL] [Abstract][Full Text] [Related]
60. Aminopeptidase N (CD13) as a target for cancer chemotherapy.
Wickström M; Larsson R; Nygren P; Gullbo J
Cancer Sci; 2011 Mar; 102(3):501-8. PubMed ID: 21205077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
